Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke
Primary Purpose
Chronic Stroke
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
LSVT®BIG Intervention
Waitlist Control
Sponsored by

About this trial
This is an interventional treatment trial for Chronic Stroke focused on measuring Upper Extremity Hemiparesis
Eligibility Criteria
Inclusion Criteria:
- Age 18 or older
- Diagnosis of first-ever ischemic stroke at least 6 months prior as confirmed by medical records
- Has more than a moderate stroke (NIH Stroke Scale > 20)
- Can read and write English. To ensure participants can understand instructions in clinic and home exercise sessions
Exclusion Criteria:
- More than moderate motor deficits (Fugl-Meyer UE Assessment < 32/66)
- More than mild cognitive impairment (Mini-Mental Status Examination < 24)
- More than mild balance deficits (Berg Balance Scale <45)
- Minimal or no impairments from their stroke (NIH Stroke Scale < 6)
- Currently receiving occupational therapy or physical therapy services
- Has had more than one stroke
Sites / Locations
- University of Missouri
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Experimental
Waitlist Control
Arm Description
This group will receive the LSVT(R)BIG Intervention first (4 weeks) and then cross over to the Waitlist Control (no intervention for 4 weeks).
This group will receive the Waitlist Control (4 weeks) and then cross over to receive the LSVT(R)BIG Intervention (4 weeks).
Outcomes
Primary Outcome Measures
Adherence Rate
For each study participant, an percentage of clinic visits and home exercises completed will be calculated. Rates will be averaged within groups.
Secondary Outcome Measures
Change from baseline in Wolf Motor Function Test (WMFT)
Assessment of upper extremity motor function.
Change from baseline in Canadian Occupational Performance Measure (COPM)
The Canadian occupational Performance Measure is a measure of the subject's self-rated performance and satisfaction of their performance with 5 self-identified areas of occupation/activities.
Change from baseline in Performance Assessment of Self-Care Skills (PASS)
The Performance Assessment of Self-Care Skills (PASS) assesses basic self-care and instrumental activities of daily living. Subscales: Independence, Safety, Adequacy (minimum: 0, maximum: 3). There is no total score reported.
Change from baseline in PROMIS-43
General assessment of quality of life and participation in daily life. Assessment is from the standardized NIH Toolbox. T-scores are reported on scale of 0-100 (50 is average).
Change from baseline in Modified Ashworth Scale (MAS)
Assess muscle tone of various joints. Only joints with any spasticity will be recorded. Scale ranges from 0 (no spasticity) to 3 (rigid joint).
Change from baseline in Upper Extremity Range of Motion
Angle (degrees) of the upper extremities as measured by a goniometer.
Change from baseline in Upper Extremity Strength
Upper extremity strength will be assessed through Manual Muscle Testing.
Retention Rate
Rate: Number of study participants completing the study relative to the number initially enrolled in the study
Recruitment Rate
A log of calls will be kept. The number of screened study participants relative to the total number of calls made will be used to calculate recruitment rate.
Full Information
NCT ID
NCT03602443
First Posted
June 19, 2018
Last Updated
March 23, 2020
Sponsor
University of Missouri-Columbia
Collaborators
American Occupational Therapy Foundation
1. Study Identification
Unique Protocol Identification Number
NCT03602443
Brief Title
Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke
Official Title
Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
March 2020
Overall Recruitment Status
Completed
Study Start Date
August 6, 2018 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
December 31, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Missouri-Columbia
Collaborators
American Occupational Therapy Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Evaluate feasibility (acceptability, subject recruitment/retention, willingness to be randomized, and adherence rates) of delivering the Lee Silverman Voice Treatment®-BIG (LSVT®BIG) intervention with individuals with chronic stroke. Evaluate preliminary effect of the LSVT®BIG intervention on motor function and occupational performance with individuals with chronic stroke.
Detailed Description
Literature suggests the Lee Silverman Voice Treatment®-BIG (LSVT-BIG®) program is an effective intervention for individuals with Parkinson's Disease (Ebersbach et al., 2015); however, no literature or research exists on the use of this program as an intervention for individuals with stroke. Therefore, this project aims to measure the effectiveness of the LSVT®BIG program with one individual with a stroke to determine if LSVT®BIG is a feasible and effective occupational therapy intervention for this population. The LSVT®BIG program is an intensive program with hands-on treatment sessions 4 days per week for 4 weeks. Clients complete home exercises every day that enhance the hands-on treatment and help promote carry-over of skills learned to daily tasks. The investigators have completed two case studies with clients with chronic stroke who demonstrated improved outcomes in upper extremity motor function and occupational performance. The purpose of this study is to test the LSVT®BIG intervention with a larger clinical population and to demonstrate that LSVT®BIG is an effective and feasible treatment option for improvement in occupational performance and upper extremity motor function with individuals with stroke.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Stroke
Keywords
Upper Extremity Hemiparesis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
The study is a randomized, wait-list, cross-over design pilot feasibility trial.
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
5 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Experimental
Arm Type
Experimental
Arm Description
This group will receive the LSVT(R)BIG Intervention first (4 weeks) and then cross over to the Waitlist Control (no intervention for 4 weeks).
Arm Title
Waitlist Control
Arm Type
Other
Arm Description
This group will receive the Waitlist Control (4 weeks) and then cross over to receive the LSVT(R)BIG Intervention (4 weeks).
Intervention Type
Behavioral
Intervention Name(s)
LSVT®BIG Intervention
Intervention Description
Participants will complete LSVT®BIG intervention which consists of 16 one-hour sessions on 4 consecutive days for 4 weeks, and a home program component.
Intervention Type
Behavioral
Intervention Name(s)
Waitlist Control
Intervention Description
Participants randomized to this arm will be followed for the 4-week time period. We will track engagement in any daily exercise (not therapy services) through self-report.
Primary Outcome Measure Information:
Title
Adherence Rate
Description
For each study participant, an percentage of clinic visits and home exercises completed will be calculated. Rates will be averaged within groups.
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Change from baseline in Wolf Motor Function Test (WMFT)
Description
Assessment of upper extremity motor function.
Time Frame
4 weeks
Title
Change from baseline in Canadian Occupational Performance Measure (COPM)
Description
The Canadian occupational Performance Measure is a measure of the subject's self-rated performance and satisfaction of their performance with 5 self-identified areas of occupation/activities.
Time Frame
4 weeks
Title
Change from baseline in Performance Assessment of Self-Care Skills (PASS)
Description
The Performance Assessment of Self-Care Skills (PASS) assesses basic self-care and instrumental activities of daily living. Subscales: Independence, Safety, Adequacy (minimum: 0, maximum: 3). There is no total score reported.
Time Frame
4 weeks
Title
Change from baseline in PROMIS-43
Description
General assessment of quality of life and participation in daily life. Assessment is from the standardized NIH Toolbox. T-scores are reported on scale of 0-100 (50 is average).
Time Frame
4 weeks
Title
Change from baseline in Modified Ashworth Scale (MAS)
Description
Assess muscle tone of various joints. Only joints with any spasticity will be recorded. Scale ranges from 0 (no spasticity) to 3 (rigid joint).
Time Frame
4 weeks
Title
Change from baseline in Upper Extremity Range of Motion
Description
Angle (degrees) of the upper extremities as measured by a goniometer.
Time Frame
4 weeks
Title
Change from baseline in Upper Extremity Strength
Description
Upper extremity strength will be assessed through Manual Muscle Testing.
Time Frame
4 weeks
Title
Retention Rate
Description
Rate: Number of study participants completing the study relative to the number initially enrolled in the study
Time Frame
1 year
Title
Recruitment Rate
Description
A log of calls will be kept. The number of screened study participants relative to the total number of calls made will be used to calculate recruitment rate.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18 or older
Diagnosis of first-ever ischemic stroke at least 6 months prior as confirmed by medical records
Has more than a moderate stroke (NIH Stroke Scale > 20)
Can read and write English. To ensure participants can understand instructions in clinic and home exercise sessions
Exclusion Criteria:
More than moderate motor deficits (Fugl-Meyer UE Assessment < 32/66)
More than mild cognitive impairment (Mini-Mental Status Examination < 24)
More than mild balance deficits (Berg Balance Scale <45)
Minimal or no impairments from their stroke (NIH Stroke Scale < 6)
Currently receiving occupational therapy or physical therapy services
Has had more than one stroke
Facility Information:
Facility Name
University of Missouri
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65211
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
All de-identified clinical outcome assessment data with accompanying key will be deposited in MOspace Institutional Repository, the University of Missouri's digital institutional repository. MOspace is based on MIT's DSpace technology and is a joint venture of the University of Missouri's Division of Information Technology and the University Libraries. MOspace items will include appropriate metadata and a permanent URL. Items will be freely available via the MOspace web site at https://mospace.umsystem.edu and will be searchable via Google and other search engines.
Citations:
PubMed Identifier
24231400
Citation
Ebersbach G, Ebersbach A, Gandor F, Wegner B, Wissel J, Kupsch A. Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study. Arch Phys Med Rehabil. 2014 May;95(5):996-9. doi: 10.1016/j.apmr.2013.10.020. Epub 2013 Nov 11.
Results Reference
background
PubMed Identifier
24872078
Citation
Ebersbach G, Grust U, Ebersbach A, Wegner B, Gandor F, Kuhn AA. Amplitude-oriented exercise in Parkinson's disease: a randomized study comparing LSVT-BIG and a short training protocol. J Neural Transm (Vienna). 2015 Feb;122(2):253-6. doi: 10.1007/s00702-014-1245-8. Epub 2014 May 29. Erratum In: J Neural Transm (Vienna). 2015 Feb;122(2):257.
Results Reference
background
PubMed Identifier
16283401
Citation
Farley BG, Koshland GF. Training BIG to move faster: the application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson's disease. Exp Brain Res. 2005 Dec;167(3):462-7. doi: 10.1007/s00221-005-0179-7. Epub 2005 Nov 11.
Results Reference
background
PubMed Identifier
21130938
Citation
Gearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011 Feb;31(1):79-88. doi: 10.1016/j.cpr.2010.09.007. Epub 2010 Oct 7.
Results Reference
background
PubMed Identifier
19289487
Citation
Lin KC, Hsieh YW, Wu CY, Chen CL, Jang Y, Liu JS. Minimal detectable change and clinically important difference of the Wolf Motor Function Test in stroke patients. Neurorehabil Neural Repair. 2009 Jun;23(5):429-34. doi: 10.1177/1545968308331144. Epub 2009 Mar 16.
Results Reference
background
PubMed Identifier
30157019
Citation
Proffitt RM, Henderson W, Scholl S, Nettleton M. Lee Silverman Voice Treatment BIG(R) for a Person With Stroke. Am J Occup Ther. 2018 Sep/Oct;72(5):7205210010p1-7205210010p6. doi: 10.5014/ajot.2018.028217.
Results Reference
background
PubMed Identifier
26864411
Citation
Winstein CJ, Wolf SL, Dromerick AW, Lane CJ, Nelsen MA, Lewthwaite R, Cen SY, Azen SP; Interdisciplinary Comprehensive Arm Rehabilitation Evaluation (ICARE) Investigative Team. Effect of a Task-Oriented Rehabilitation Program on Upper Extremity Recovery Following Motor Stroke: The ICARE Randomized Clinical Trial. JAMA. 2016 Feb 9;315(6):571-81. doi: 10.1001/jama.2016.0276.
Results Reference
background
PubMed Identifier
11441212
Citation
Wolf SL, Catlin PA, Ellis M, Archer AL, Morgan B, Piacentino A. Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke. 2001 Jul;32(7):1635-9. doi: 10.1161/01.str.32.7.1635.
Results Reference
background
Learn more about this trial
Feasibility of the Lee Silverman Voice Treatment®-BIG Intervention in Stroke
We'll reach out to this number within 24 hrs